Literature DB >> 33613455

Natural History of Renal Neuroendocrine Neoplasms: A NET by Any Other Name?

Andrew H Nguyen1, Michael P O'Leary1, James P De Andrade2, Philip H G Ituarte1, Jonathan Kessler3, Daneng Li4, Gagandeep Singh1, Sue Chang5.   

Abstract

Renal neuroendocrine neoplasms are rare, with descriptions of cases limited to individual reports and small series. The natural history of this group of neuroendocrine neoplasms is poorly understood. In this study, we queried the Surveillance, Epidemiology and End Results (SEER) database over a four-decade period where we identified 166 cases of primary renal neuroendocrine neoplasms. We observed a 5-year overall survival of 50%. On multivariate analysis, survival was influenced by stage, histology, and if surgery was performed. We observed that patients managed by operative management had a greater frequency of localized or regional stage disease as well as a greater frequency of neuroendocrine tumor, grade 1 histology; whereas those managed non-operatively tended to have distant disease and histologies of neuroendocrine carcinoma, NOS and small cell neuroendocrine carcinoma. This is the largest description of patients with renal neuroendocrine neoplasms. Increased survival was observed in patients with earlier stage and favorable histologies.
Copyright © 2021 Nguyen, O’Leary, De Andrade, Ituarte, Kessler, Li, Singh and Chang.

Entities:  

Keywords:  kidney; neuroendocrine carcinoma ; neuroendocrine neoplasm; neuroendocrine tumor; renal

Mesh:

Year:  2021        PMID: 33613455      PMCID: PMC7894255          DOI: 10.3389/fendo.2020.624251

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  14 in total

1.  Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach.

Authors:  Malcolm H Squires; N Volkan Adsay; David M Schuster; Maria C Russell; Kenneth Cardona; Keith A Delman; Joshua H Winer; Deniz Altinel; Juan M Sarmiento; Bassel El-Rayes; Natalyn Hawk; Charles A Staley; Shishir K Maithel; David A Kooby
Journal:  Ann Surg Oncol       Date:  2015-03-19       Impact factor: 5.344

Review 2.  Horseshoe kidney is associated with an increased relative risk of primary renal carcinoid tumor.

Authors:  B Krishnan; L D Truong; G Saleh; D M Sirbasku; K M Slawin
Journal:  J Urol       Date:  1997-06       Impact factor: 7.450

Review 3.  Primary carcinoid tumors of the kidney.

Authors:  Frederico R Romero; Soroush Rais-Bahrami; Sompol Permpongkosol; Samson W Fine; Sahar Kohanim; Thomas W Jarrett
Journal:  J Urol       Date:  2006-12       Impact factor: 7.450

Review 4.  Carcinoid tumors of the urinary tract and prostate.

Authors:  Rajmohan Murali; Kenneth Kneale; Nestor Lalak; Warick Delprado
Journal:  Arch Pathol Lab Med       Date:  2006-11       Impact factor: 5.534

Review 5.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

Review 6.  Primary renal carcinoid: treatment and prognosis.

Authors:  Taner Korkmaz; Selcuk Seber; Dilek Yavuzer; Mahmut Gumus; N Serdar Turhal
Journal:  Crit Rev Oncol Hematol       Date:  2013-03-09       Impact factor: 6.312

Review 7.  Bronchopulmonary neuroendocrine tumors.

Authors:  Bjorn I Gustafsson; Mark Kidd; Anthony Chan; Max V Malfertheiner; Irvin M Modlin
Journal:  Cancer       Date:  2008-07-01       Impact factor: 6.860

Review 8.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.

Authors:  Holger Moch; Antonio L Cubilla; Peter A Humphrey; Victor E Reuter; Thomas M Ulbright
Journal:  Eur Urol       Date:  2016-02-28       Impact factor: 20.096

9.  Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.

Authors:  Arvind Dasari; Chan Shen; Daniel Halperin; Bo Zhao; Shouhao Zhou; Ying Xu; Tina Shih; James C Yao
Journal:  JAMA Oncol       Date:  2017-10-01       Impact factor: 31.777

10.  A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

Authors:  Guido Rindi; David S Klimstra; Behnoush Abedi-Ardekani; Sylvia L Asa; Frederik T Bosman; Elisabeth Brambilla; Klaus J Busam; Ronald R de Krijger; Manfred Dietel; Adel K El-Naggar; Lynnette Fernandez-Cuesta; Günter Klöppel; W Glenn McCluggage; Holger Moch; Hiroko Ohgaki; Emad A Rakha; Nicholas S Reed; Brian A Rous; Hironobu Sasano; Aldo Scarpa; Jean-Yves Scoazec; William D Travis; Giovanni Tallini; Jacqueline Trouillas; J Han van Krieken; Ian A Cree
Journal:  Mod Pathol       Date:  2018-08-23       Impact factor: 7.842

View more
  1 in total

Review 1.  Neuroendocrine Neoplasms of the Female Genitourinary Tract: A Comprehensive Overview.

Authors:  Mayur Virarkar; Sai Swarupa Vulasala; Dheeraj Gopireddy; Ajaykumar C Morani; Taher Daoud; Rebecca Waters; Priya Bhosale
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.